ArticleBMJ open2023

(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).

Anouk A Kruiswijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.